News headlines about Surgery Partners (NASDAQ:SGRY) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Surgery Partners earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.6989661438508 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

A number of research firms have issued reports on SGRY. BidaskClub upgraded Surgery Partners from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. Zacks Investment Research upgraded Surgery Partners from a “hold” rating to a “buy” rating and set a $22.00 target price on the stock in a research note on Wednesday, August 2nd. Raymond James Financial, Inc. reiterated a “market perform” rating on shares of Surgery Partners in a research note on Wednesday, August 9th. Stifel Nicolaus cut Surgery Partners from a “hold” rating to a “sell” rating and cut their target price for the company from $21.00 to $17.00 in a research note on Wednesday, August 9th. Finally, Citigroup Inc. reiterated a “buy” rating and issued a $17.00 target price (down from $28.00) on shares of Surgery Partners in a research note on Friday, August 11th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $19.33.

Shares of Surgery Partners (NASDAQ:SGRY) traded down 4.00% during midday trading on Friday, hitting $9.60. 286,529 shares of the company were exchanged. The firm has a market cap of $468.59 million, a P/E ratio of 63.16 and a beta of 2.02. Surgery Partners has a one year low of $8.52 and a one year high of $24.05. The company’s 50 day moving average price is $11.41 and its 200 day moving average price is $18.21.

In other news, major shareholder H.I.G. Surgery Centers, Llc sold 26,455,651 shares of the company’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $19.00, for a total transaction of $502,657,369.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 7.50% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.dailypolitical.com/2017/09/24/surgery-partners-sgry-getting-somewhat-favorable-media-coverage-report-shows.html.

Surgery Partners Company Profile

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Insider Buying and Selling by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.